The company will invest Rs 55 crore in the mill, which is a part of its backward integration strategy
The sale is consistent with Shell's strategy to concentrate its downstream footprint on a smaller number of assets and markets where it can be most competitive
The strategic partnership will focus on research in pharmaceutical processes and product development
As a part of its consolidation plans, GM will shut down Halol (Gujarat) plant by 2016, while it will expand capacity at Talegaon (Maharashtra) manufacturing plant
The 2-MW solar power plant in Osmanabad (Maharashtra) to generate electricity for the company's captive use
Kleiss Gears' metal gear systems will complement with high-performance engineering polymer gears such as Victrex's PEEK
Recovery of the auto sector is expected to create higher tyres demand, which in turn is likely to drive the synthetic rubber and butadiene market through 2020, says a TechSci Research report
The market for aerogels, vacuum insulation panels and phase-change materials lies in non-building applications like refrigeration and logistics, says a Lux Research report
The company, which will spent the capex over five years, will set up a new plant for manufacturing high-end engineered pumps for super critical thermal power plants
As per the contract, Siemens will supply 400 kV and 220kV GIS for a substation project of Himachal Pradesh Power Transmission Corporation Limited
With India ranking fourth in the list of countries that received warning letters and import alerts from US FDA, pharma companies will have to put in more quality control measures in place
Acquisition propels Solvay to world's second largest player in aerospace composite materials, and reinforces advanced formulations with the world's number one mining chemical business
Esmolol hydrochloride injection is generic version of Baxter Healthcare's Brevibloc injection
The subsidiary, Intelent, aims to address the $300 billion healthcare and life sciences market by providing clients offerings in the areas of data integration and advanced analytics
He replaces Abhijit Barve, who has moved back to the US
Temmler's business has a strong strategic fit with Lupin's Hormosan business in Germany, enabling Lupin to bring an enhanced specialty CNS portfolio in the German market
Following the completion of the acquisition, Teva is expected to have pro forma sales of approximately $26 billion and EBITDA of approximately $9.5 billion in 2016
One of the biggest factors that may disrupt capital projects is a chronic escalation of project costs. New thinking is required to overcome the project cost and execution challenges
While BASF will use its share of ammonia from the plant to produce caprolactam, Yara will market the remainder to industrial & agricultural sectors in North America
The devaluation of the Euro stimulated overseas exports while the domestic demand for chemical products remained restrained, says German chemical industry association (VCI)